Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
about
STAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver DamageXenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the LiverTh22 cell accumulation is associated with colorectal cancer developmentBiologically active, high levels of interleukin-22 inhibit hepatic gluconeogenesis but do not affect obesity and its metabolic consequences.Recent advancement of molecular mechanisms of liver fibrosis.IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma.Though Active on RINm5F Insulinoma Cells and Cultured Pancreatic Islets, Recombinant IL-22 Fails to Modulate Cytotoxicity and Disease in a Protocol of Streptozotocin-Induced Experimental DiabetesEndogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury.A Protective Function of IL-22BP in Ischemia Reperfusion and Acetaminophen-Induced Liver Injury.CYP2E1 regulates the development of radiation-induced pulmonary fibrosis via ER stress- and ROS-dependent mechanisms.Establishment of a model of acetaminophen-induced hepatotoxicity in different weekly-aged ICR mice.A Prominent Role of Interleukin-18 in Acetaminophen-Induced Liver Injury Advocates Its Blockage for Therapy of Hepatic Necroinflammation.The role of IL-22 in the resolution of sterile and nonsterile inflammation.Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury.
P2860
Q26747404-B3AD2289-31EB-43D4-B2D3-8AA520478D3BQ26800213-36B0A31D-92C8-414E-966F-BFEB5E16CD55Q35375460-87D4842C-A287-4B71-9B3A-A9D65A5C75EBQ35710971-312E177C-9C62-49CF-AC28-32FCED0CB5A1Q38419194-5009980F-567B-4436-87D6-7A02FB0DA450Q38626350-2FC51A00-B244-426E-A945-D7BEE241B521Q38801112-1D354BC6-CB29-44FF-8A22-74763469544FQ39792098-5AC829EB-353B-46D5-893A-A2B1478E3956Q41480019-DC3E08D8-6A91-4D34-8BCC-203201E1948CQ45874050-FEBF6AC3-A8DD-41FB-B857-69A583D37850Q46322665-64F6E3AF-22DE-4B40-B99D-D802A7BF7746Q46773613-16D2F653-B26E-4E12-8FBA-4F2C55FCFA46Q50295997-83019A28-4CB3-48DB-B501-A633BC0D78D0Q54224246-6CC3064F-0A07-49F0-819F-6AA27284ECD7Q55313239-AAAF2068-2D82-4E08-B6EB-051F163711FB
P2860
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@ast
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@en
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@nl
type
label
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@ast
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@en
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@nl
prefLabel
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@ast
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@en
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@nl
P2093
P2860
P356
P1476
Acute and chronic effects of IL-22 on acetaminophen-induced liver injury
@en
P2093
Brittany V Martin-Murphy
Cynthia Ju
Dechun Feng
Honglei Weng
Steven Dooley
Xiaoni Kong
P2860
P304
P356
10.4049/JIMMUNOL.1400588
P407
P577
2014-07-25T00:00:00Z